Abstract:Fluorine is a key element in the synthesis of molecules broadly used in medicine, agriculture and materials. Addition of fluorine to organic structures represents a unique strategy for tuning molecular properties, yet this atom is rarely found in Nature and approaches to integrate fluorometabolites into the biochemistry of living cells are scarce. In this work, synthetic gene circuits for organofluorine biosynthesis are implemented in the platform bacterium Pseudomonas putida. By harnessing fluoride-responsive… Show more
“…The biosynthetic repertoire of Pseudomonas together with implementation of heterologous pathways allows the utilisation of various substrates and synthesis of highly diverse products such as aromatics, glycolipids, and terpenoids [2][3][4]. De novo biosynthesis of fluorometabolites from mineral fluoride has recently paved a new way to fluorinated building blocks [12]. An ideal cell factory for respective biotechnological applications is composed of a chassis that exhibits inherent or engineered tolerance to the involved substrate and product, and a metabolic pathway with optimal flux between the two.…”
Section: Engineering Of Optimal Flux In Cell Factories With Novel Pathwaysmentioning
confidence: 99%
“…Another emerging strategy to achieve a higher and more balanced flux is to spatially organise enzymes within synthetic scaffolds [164,165] to create high local concentrations of metabolites and enzymes, with well-defined stoichiometry to support immediate conversion without diffusion of intermediates. All these strategies (Figure 3) together with an increasing understanding of tolerance traits will be instrumental for effective production applications and expanding the catalytic landscape of Pseudomonas towards novel chemistries [12,166].…”
Section: Engineering Of Optimal Flux In Cell Factories With Novel Pathwaysmentioning
Biotechnological production in bacteria enables access to numerous valuable chemical compounds. Nowadays, advanced molecular genetic toolsets, enzyme engineering as well as the combinatorial use of biocatalysts, pathways, and circuits even bring new-to-nature compounds within reach. However, the associated substrates and biosynthetic products often cause severe chemical stress to the bacterial hosts. Species of the Pseudomonas clade thus represent especially valuable chassis as they are endowed with multiple stress response mechanisms, which allow them to cope with a variety of harmful chemicals. A built-in cell envelope stress response enables fast adaptations that sustain membrane integrity under adverse conditions. Further, effective export machineries can prevent intracellular accumulation of diverse harmful compounds. Finally, toxic chemicals such as reactive aldehydes can be eliminated by oxidation and stress-induced damage can be recovered. Exploiting and engineering these features will be essential to support an effective production of natural compounds and new chemicals. In this article, we therefore discuss major resistance strategies of Pseudomonads along with approaches pursued for their targeted exploitation and engineering in a biotechnological context. We further highlight strategies for the identification of yet unknown tolerance-associated genes and their utilisation for engineering next-generation chassis and finally discuss effective measures for pathway fine-tuning to establish stable cell factories for the effective production of natural compounds and novel biochemicals.
“…The biosynthetic repertoire of Pseudomonas together with implementation of heterologous pathways allows the utilisation of various substrates and synthesis of highly diverse products such as aromatics, glycolipids, and terpenoids [2][3][4]. De novo biosynthesis of fluorometabolites from mineral fluoride has recently paved a new way to fluorinated building blocks [12]. An ideal cell factory for respective biotechnological applications is composed of a chassis that exhibits inherent or engineered tolerance to the involved substrate and product, and a metabolic pathway with optimal flux between the two.…”
Section: Engineering Of Optimal Flux In Cell Factories With Novel Pathwaysmentioning
confidence: 99%
“…Another emerging strategy to achieve a higher and more balanced flux is to spatially organise enzymes within synthetic scaffolds [164,165] to create high local concentrations of metabolites and enzymes, with well-defined stoichiometry to support immediate conversion without diffusion of intermediates. All these strategies (Figure 3) together with an increasing understanding of tolerance traits will be instrumental for effective production applications and expanding the catalytic landscape of Pseudomonas towards novel chemistries [12,166].…”
Section: Engineering Of Optimal Flux In Cell Factories With Novel Pathwaysmentioning
Biotechnological production in bacteria enables access to numerous valuable chemical compounds. Nowadays, advanced molecular genetic toolsets, enzyme engineering as well as the combinatorial use of biocatalysts, pathways, and circuits even bring new-to-nature compounds within reach. However, the associated substrates and biosynthetic products often cause severe chemical stress to the bacterial hosts. Species of the Pseudomonas clade thus represent especially valuable chassis as they are endowed with multiple stress response mechanisms, which allow them to cope with a variety of harmful chemicals. A built-in cell envelope stress response enables fast adaptations that sustain membrane integrity under adverse conditions. Further, effective export machineries can prevent intracellular accumulation of diverse harmful compounds. Finally, toxic chemicals such as reactive aldehydes can be eliminated by oxidation and stress-induced damage can be recovered. Exploiting and engineering these features will be essential to support an effective production of natural compounds and new chemicals. In this article, we therefore discuss major resistance strategies of Pseudomonads along with approaches pursued for their targeted exploitation and engineering in a biotechnological context. We further highlight strategies for the identification of yet unknown tolerance-associated genes and their utilisation for engineering next-generation chassis and finally discuss effective measures for pathway fine-tuning to establish stable cell factories for the effective production of natural compounds and novel biochemicals.
“…The recently demonstrated implantation of neometabolism for in vivo biofluorination in P . putida [ 159 ] will trigger further developments in this direction.…”
Growing environmental concern sparks renewed interest in the sustainable production of (bio)materials that can replace oil‐derived goods. Polyhydroxyalkanoates (PHAs) are isotactic polymers that play a critical role in the central metabolism of producer bacteria, as they act as dynamic reservoirs of carbon and reducing equivalents. PHAs continue to attract industrial attention as a starting point toward renewable, biodegradable, biocompatible, and versatile thermoplastic and elastomeric materials. Pseudomonas species have been known for long as efficient biopolymer producers, especially for medium‐chain‐length PHAs. The surge of synthetic biology and metabolic engineering approaches in recent years offers the possibility of exploiting the untapped potential of Pseudomonas cell factories for the production of tailored PHAs. In this article, an overview of the metabolic and regulatory circuits that rule PHA accumulation in Pseudomonas putida is provided, and approaches leading to the biosynthesis of novel polymers (e.g., PHAs including nonbiological chemical elements in their structures) are discussed. The potential of novel PHAs to disrupt existing and future market segments is closer to realization than ever before. The review is concluded by pinpointing challenges that currently hinder the wide adoption of bio‐based PHAs, and strategies toward programmable polymer biosynthesis from alternative substrates in engineered P. putida strains are proposed.
“…Recently, Calero et al connected a synthetic fluorideresponsive riboswitch (FRS) to the induction of artificial metabolic pathways for the biosynthesis of fluoronucleotides and fluorosugars in engineered P. putida using inorganic fluoride as both the only fluorine source (i.e., substrate) and as the inducer of the genetic circuit. 124 The FRS post-transcriptionally (Fig. 3B, bottom) binds fluoride ions, which triggers the translation of the orthogonal T7 RNA polymerase, subsequently enabling the T7 promoter-controlled production of fluorinases and a purine nucleotide phosphorylase.…”
Section: Biosensorsmentioning
confidence: 99%
“…, substrate) and as the inducer of the genetic circuit. 124 The FRS post-transcriptionally ( Fig. 3B , bottom) binds fluoride ions, which triggers the translation of the orthogonal T7 RNA polymerase, subsequently enabling the T7 promoter-controlled production of fluorinases and a purine nucleotide phosphorylase.…”
Section: Advanced Technologies For the Discovery And Design Of Novel Enzymes And Enzymatic Cascadesmentioning
Technological developments enable the discovery of novel enzymes, the advancement of enzyme cascade designs and pathway engineering, moving biocatalysis into an era of technology integration, intelligent manufacturing and enzymatic total synthesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.